• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. EQUINOXE; GLENOID BASEPLATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. EQUINOXE; GLENOID BASEPLATE Back to Search Results
Device Problems Loose or Intermittent Connection (1371); Loosening of Implant Not Related to Bone-Ingrowth (4002)
Patient Problems Failure of Implant (1924); No Known Impact Or Consequence To Patient (2692)
Event Date 12/01/2018
Event Type  Injury  
Manufacturer Narrative
This event report was received through clinical data collection activities.Pending evaluation.
 
Event Description
Index surgery: (b)(6) 2015.Aseptic glenoid loosening.Loose baseplate.Minimally symptomatic until (b)(6) 2018 when he had sudden pain & decreased motion.The case report form indicates this event is possibly related to devices and possibly related to procedure.
 
Manufacturer Narrative
Section h10: (b3) 01-dec-2018 (e3) occupation: physician (h3) index surgery: 9/16/2015.Aseptic glenoid loosening.Loose baseplate.Minimally symptomatic until 12/2018 when he had sudden pain & decreased motion.The case report form indicates this event is possibly related to devices and possibly related to procedure.This event report was received through clinical data collection activities.The report indicates the baseplate was loose, the most likely cause of the loosening is related to the patient condition.Equinoxe is intended for individuals who have degenerative disease of the shoulder.Product was not returned.No additional information provided.Indications for use: the equinoxe shoulder system is indicated for use in skeletally mature individuals with degenerative diseases or fractures of the glenohumeral joint where total or hemi- arthroplasty is determined by the surgeon to be the preferred method of treatment.Per ifu # 700-096-060 rev.M states in post op instructions: all patients should be instructed on the limitations of the prosthesis and the possibility of subsequent surgery.The patient should be cautioned to monitor activities and protect the replaced joint from unreasonable stresses, and follow the written instructions of the physician with respect to follow-up care and treatment.The patient should be warned against unassisted activity, particularly in lifting, and that active motion should not be initiated until recommended by the surgeon in order to ensure subscapularis healing is complete.Patients must be informed that their weight and activity level may affect the longevity of the implant.Patients should be advised to report any pain, decrease in range of motion, swelling, fever, or unusual sounds as this may indicate positional changes in the implant that could lead to premature failure.Normal wear of the implant given the state of knowledge at the time of its design cannot in any way be considered to constitute a dysfunction or deterioration in the characteristics of the implant.Failure to adhere to these recommendations will result in increased probability of poor function, loosening, wear, fracture or premature failure.No information provided in the following section(s): b6, b7, d4, d6, d7, d11, g5, g8, h4, h6, h7 section h11: corrections made in the following section(s): (e1) initial reporter should be dr.Wright (section f) please disregard f6 and f8.These were entered in error.(g1) updated contact name and address to kate jacobson (g4) initial awareness date in initial submission should have been 08-may-2019.(h5) labeled for single use should be yes.
 
Manufacturer Narrative
Section h10: (d6) if implanted, give date: (b)(6) 2015.(h6) evaluation codes: 1924, 4002.Section h11: *the following sections have corrected information: (h3) the glenoid loosening reported was likely the result of an insufficient bond between the glenoid baseplate and the bone, which led to aseptic (non-infected) glenoid loosening, pain, and decreased motion.However, this cannot be confirmed because the component has not been revised and, therefore, is not available for evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EQUINOXE
Type of Device
GLENOID BASEPLATE
Manufacturer (Section D)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
MDR Report Key8253441
MDR Text Key133237160
Report Number1038671-2019-01023
Device Sequence Number1
Product Code KWT
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 02/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/16/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received02/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
UNK.
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient Weight167
-
-